Bayer AG (BAYZF)
56.34
-1.01
(-1.76%)
USD |
OTCM |
Aug 27, 16:00
Bayer Price to Book Value : 1.636 for Aug. 27, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 27, 2026 | 1.636 |
| August 26, 2026 | 1.666 |
| August 25, 2026 | 1.666 |
| August 24, 2026 | 1.632 |
| August 21, 2026 | 1.625 |
| August 20, 2026 | 1.639 |
| August 19, 2026 | 1.586 |
| August 18, 2026 | 1.586 |
| August 17, 2026 | 1.586 |
| August 14, 2026 | 1.586 |
| August 13, 2026 | 1.586 |
| August 12, 2026 | 1.625 |
| August 11, 2026 | 1.652 |
| August 10, 2026 | 1.652 |
| August 07, 2026 | 1.652 |
| August 06, 2026 | 1.652 |
| August 05, 2026 | 1.656 |
| August 04, 2026 | 1.617 |
| August 03, 2026 | 1.572 |
| July 31, 2026 | 1.604 |
| July 30, 2026 | 1.620 |
| July 29, 2026 | 1.561 |
| July 28, 2026 | 1.534 |
| July 27, 2026 | 1.534 |
| July 24, 2026 | 1.534 |
| Date | Value |
|---|---|
| July 23, 2026 | 1.534 |
| July 22, 2026 | 1.596 |
| July 21, 2026 | 1.596 |
| July 20, 2026 | 1.596 |
| July 17, 2026 | 1.596 |
| July 16, 2026 | 1.596 |
| July 15, 2026 | 1.596 |
| July 14, 2026 | 1.627 |
| July 13, 2026 | 1.637 |
| July 10, 2026 | 1.653 |
| July 09, 2026 | 1.679 |
| July 08, 2026 | 1.653 |
| July 07, 2026 | 1.701 |
| July 06, 2026 | 1.701 |
| July 02, 2026 | 1.743 |
| July 01, 2026 | 1.604 |
| June 30, 2026 | 1.598 |
| June 29, 2026 | 1.547 |
| June 26, 2026 | 1.567 |
| June 25, 2026 | 1.592 |
| June 24, 2026 | 1.303 |
| June 23, 2026 | 1.303 |
| June 22, 2026 | 1.276 |
| June 18, 2026 | 1.310 |
| June 17, 2026 | 1.310 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Merck KGaA | 2.063 |
| Breakthrough Chemistry, Inc. | 4.474 |
| Cardiac Biotech Solutions, Inc. | -- |
| Fresenius SE & Co. KGaA | 1.342 |
| Carl Zeiss Meditec AG | 3.388 |
Price to Book Value Related Metrics
| PS Ratio | 1.046 |
| Price to Free Cash Flow | 62.40 |
| Price | 56.34 |
| Earnings Yield | -3.63% |
| Market Cap | 55.35B |
| Operating PE Ratio | 7.571 |
| Normalized PE Ratio | 28.52 |